2024-11-19 |
2024-11-19 |
B
Purchase
|
Gall Matthew
Chief Financial Officer
Officer
|
5,000
+8.3%
7.73
USD 38,635
|
5,000
+8.3%
|
7.73
|
USD 38,635
|
|
2023-10-12 |
2023-10-12 |
B
Purchase
|
Gall Matthew
Chief Financial Officer
Officer
|
5,000
+34.7%
8.37
USD 41,850
|
5,000
+34.7%
|
8.37
|
USD 41,850
|
|
2023-08-25 |
2023-08-23 |
S
Sale
|
Boxer Capital, LLC
See remarks
|
219,638
-10.9%
16.87
USD 3,705,293
|
219,638
-10.9%
|
16.87
|
USD 3,705,293
|
|
2023-08-25 |
2023-08-23 |
S
Sale
|
Boxer Capital, LLC
See remarks
|
95,516
-4.5%
15.63
USD 1,492,915
|
95,516
-4.5%
|
15.63
|
USD 1,492,915
|
|
2023-08-25 |
2023-08-23 |
S
Sale
|
Boxer Capital, LLC
See remarks
|
34,846
-1.6%
14.19
USD 494,465
|
34,846
-1.6%
|
14.19
|
USD 494,465
|
|
2022-06-10 |
2022-06-09 |
S
Sale
|
Hallal David
Non-Executive Director
|
1,171
-100.0%
19.51
USD 22,846
|
1,171
-100.0%
|
19.51
|
USD 22,846
|
|
2022-06-10 |
2022-06-08 |
S
Sale
|
Hallal David
Non-Executive Director
|
10,577
-100.0%
19.86
USD 210,059
|
10,577
-100.0%
|
19.86
|
USD 210,059
|
|
2022-06-10 |
2022-06-08 |
S
Sale
|
Hallal David
Non-Executive Director
|
11,899
-100.0%
20.39
USD 242,621
|
11,899
-100.0%
|
20.39
|
USD 242,621
|
|
2022-06-10 |
2022-06-08 |
S
Sale
|
Hallal David
Non-Executive Director
|
5,968
-100.0%
20.39
USD 121,688
|
5,968
-100.0%
|
20.39
|
USD 121,688
|
|
2022-05-11 |
2022-05-11 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
337,109
-13.5%
18.25
USD 6,151,801
|
337,109
-13.5%
|
18.25
|
USD 6,151,801
|
|
2022-05-11 |
2022-05-11 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
891
-0.0%
17.53
USD 15,621
|
891
-0.0%
|
17.53
|
USD 15,621
|
|
2022-05-11 |
2022-05-10 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
4,850
-0.2%
24.77
USD 120,112
|
4,850
-0.2%
|
24.77
|
USD 120,112
|
|
2022-05-11 |
2022-05-10 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
95,150
-3.7%
25.18
USD 2,395,858
|
95,150
-3.7%
|
25.18
|
USD 2,395,858
|
|
2022-05-11 |
2022-05-09 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
200,000
-7.2%
23.47
USD 4,693,120
|
200,000
-7.2%
|
23.47
|
USD 4,693,120
|
|
2022-05-11 |
2022-05-09 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
25,000
-0.9%
22.91
USD 572,723
|
25,000
-0.9%
|
22.91
|
USD 572,723
|
|
2022-05-02 |
2022-05-02 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
92,700
-3.2%
27.53
USD 2,552,328
|
92,700
-3.2%
|
27.53
|
USD 2,552,328
|
|
2022-05-02 |
2022-05-02 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
7,300
-0.3%
26.91
USD 196,407
|
7,300
-0.3%
|
26.91
|
USD 196,407
|
|
2022-05-02 |
2022-04-29 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
115,000
-3.8%
27.01
USD 3,106,668
|
115,000
-3.8%
|
27.01
|
USD 3,106,668
|
|
2022-05-02 |
2022-04-29 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
10,000
-0.3%
28.22
USD 282,154
|
10,000
-0.3%
|
28.22
|
USD 282,154
|
|
2022-05-02 |
2022-04-28 |
S
Sale
|
Davis Aaron I.
Non-Executive Director
|
150,000
-4.7%
27.40
USD 4,110,315
|
150,000
-4.7%
|
27.40
|
USD 4,110,315
|
|
2022-04-19 |
2022-04-18 |
S
Sale
|
Detheux Michel
Chief Executive Officer
Officer
|
33
-0.1%
32.64
USD 1,077
|
33
-0.1%
|
32.64
|
USD 1,077
|
|
2022-04-19 |
2022-04-18 |
S
Sale
|
Detheux Michel
Chief Executive Officer
Officer
|
11,467
-30.4%
31.87
USD 365,453
|
11,467
-30.4%
|
31.87
|
USD 365,453
|
|
2022-03-24 |
2022-03-23 |
B
Purchase
|
Davis Aaron I.
Non-Executive Director
|
20,000
+0.6%
32.85
USD 656,980
|
20,000
+0.6%
|
32.85
|
USD 656,980
|
|
2022-03-24 |
2022-03-22 |
B
Purchase
|
Davis Aaron I.
Non-Executive Director
|
5,000
+0.2%
33.43
USD 167,139
|
5,000
+0.2%
|
33.43
|
USD 167,139
|
|
2022-03-24 |
2022-03-22 |
B
Purchase
|
Davis Aaron I.
Non-Executive Director
|
3,700
+0.1%
33.09
USD 122,432
|
3,700
+0.1%
|
33.09
|
USD 122,432
|
|
2022-03-24 |
2022-03-22 |
B
Purchase
|
Davis Aaron I.
Non-Executive Director
|
21,300
+0.7%
31.88
USD 678,938
|
21,300
+0.7%
|
31.88
|
USD 678,938
|
|
2022-03-22 |
2022-03-22 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
1,548
-5.6%
36.51
USD 56,517
|
1,548
-5.6%
|
36.51
|
USD 56,517
|
|
2022-03-22 |
2022-03-22 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
1,159
-4.0%
35.22
USD 40,820
|
1,159
-4.0%
|
35.22
|
USD 40,820
|
|
2022-03-22 |
2022-03-22 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
9,908
-25.5%
34.11
USD 337,962
|
9,908
-25.5%
|
34.11
|
USD 337,962
|
|
2022-03-22 |
2022-03-22 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
5,822
-13.0%
33.44
USD 194,688
|
5,822
-13.0%
|
33.44
|
USD 194,688
|
|
2022-03-18 |
2022-03-17 |
S
Sale
|
Boxer Capital, LLC
Large shareholder
|
575,201
-15.5%
35.25
USD 20,275,835
|
575,201
-15.5%
|
35.25
|
USD 20,275,835
|
|
2022-03-14 |
2022-03-11 |
S
Sale
|
Lager Joanne Jenkins
Chief Medical Officer
Officer
|
3,500
-100.0%
36.01
USD 126,035
|
3,500
-100.0%
|
36.01
|
USD 126,035
|
|
2022-03-02 |
2022-03-01 |
S
Sale
|
McGrath Yvonne
Chief Scientific Officer
Officer
|
10,000
-100.0%
36.76
USD 367,570
|
10,000
-100.0%
|
36.76
|
USD 367,570
|
|
2022-02-24 |
2022-02-23 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
544
-1.5%
35.32
USD 19,214
|
544
-1.5%
|
35.32
|
USD 19,214
|
|
2022-02-24 |
2022-02-23 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
13,956
-28.4%
34.30
USD 478,691
|
13,956
-28.4%
|
34.30
|
USD 478,691
|
|
2022-02-14 |
2022-02-11 |
PS
Planned sale
|
Lager Joanne Jenkins
Chief Medical Officer
Officer
|
1,518
-100.0%
36.27
USD 55,058
|
1,518
-100.0%
|
36.27
|
USD 55,058
|
|
2022-02-14 |
2022-02-11 |
PS
Planned sale
|
Lager Joanne Jenkins
Chief Medical Officer
Officer
|
1,982
-56.6%
35.52
USD 70,401
|
1,982
-56.6%
|
35.52
|
USD 70,401
|
|
2022-01-26 |
2022-01-25 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
4,412
-8.2%
36.21
USD 159,759
|
4,412
-8.2%
|
36.21
|
USD 159,759
|
|
2022-01-26 |
2022-01-25 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
10,088
-15.8%
35.45
USD 357,620
|
10,088
-15.8%
|
35.45
|
USD 357,620
|
|
2022-01-18 |
2022-01-14 |
PS
Planned sale
|
Lager Joanne Jenkins
Chief Medical Officer
Officer
|
723
-100.0%
39.58
USD 28,616
|
723
-100.0%
|
39.58
|
USD 28,616
|
|
2022-01-18 |
2022-01-14 |
PS
Planned sale
|
Lager Joanne Jenkins
Chief Medical Officer
Officer
|
2,777
-79.3%
39.25
USD 108,997
|
2,777
-79.3%
|
39.25
|
USD 108,997
|
|
2022-01-06 |
2022-01-05 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
18,135
-0.7%
42.03
USD 762,214
|
18,135
-0.7%
|
42.03
|
USD 762,214
|
|
2022-01-06 |
2022-01-05 |
S
Sale
|
GADICKE ANSBERT
Large shareholder
|
30,347
-0.7%
42.03
USD 1,275,484
|
30,347
-0.7%
|
42.03
|
USD 1,275,484
|
|
2022-01-06 |
2022-01-05 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
18,135
-0.7%
42.03
USD 762,214
|
18,135
-0.7%
|
42.03
|
USD 762,214
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
7,671
-0.3%
46.47
USD 356,471
|
7,671
-0.3%
|
46.47
|
USD 356,471
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
6,768
-0.2%
45.32
USD 306,726
|
6,768
-0.2%
|
45.32
|
USD 306,726
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
19,366
-0.7%
43.20
USD 836,611
|
19,366
-0.7%
|
43.20
|
USD 836,611
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BIOVENTURES 2018, L.P.
Large shareholder
|
94,745
-3.3%
42.05
USD 3,984,027
|
94,745
-3.3%
|
42.05
|
USD 3,984,027
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
GADICKE ANSBERT
Large shareholder
|
12,829
-0.3%
46.47
USD 596,164
|
12,829
-0.3%
|
46.47
|
USD 596,164
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
GADICKE ANSBERT
Large shareholder
|
11,318
-0.2%
45.32
USD 512,932
|
11,318
-0.2%
|
45.32
|
USD 512,932
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
GADICKE ANSBERT
Large shareholder
|
32,396
-0.7%
43.20
USD 1,399,507
|
32,396
-0.7%
|
43.20
|
USD 1,399,507
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
GADICKE ANSBERT
Large shareholder
|
158,579
-3.4%
42.05
USD 6,668,247
|
158,579
-3.4%
|
42.05
|
USD 6,668,247
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
7,671
-0.3%
46.47
USD 356,471
|
7,671
-0.3%
|
46.47
|
USD 356,471
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
6,768
-0.2%
45.32
USD 306,726
|
6,768
-0.2%
|
45.32
|
USD 306,726
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
19,366
-0.7%
43.20
USD 836,611
|
19,366
-0.7%
|
43.20
|
USD 836,611
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
MPM BioVentures 2014, L.P.
Large shareholder
|
94,745
-3.3%
42.05
USD 3,984,027
|
94,745
-3.3%
|
42.05
|
USD 3,984,027
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
2,517
-100.0%
45.48
USD 114,467
|
2,517
-100.0%
|
45.48
|
USD 114,467
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
11,199
-81.6%
44.44
USD 497,701
|
11,199
-81.6%
|
44.44
|
USD 497,701
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
3,138
-18.6%
43.36
USD 136,062
|
3,138
-18.6%
|
43.36
|
USD 136,062
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
29,623
-63.7%
41.84
USD 1,239,486
|
29,623
-63.7%
|
41.84
|
USD 1,239,486
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
7,483
-0.2%
45.48
USD 340,310
|
7,483
-0.2%
|
45.48
|
USD 340,310
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
33,297
-0.9%
44.44
USD 1,479,772
|
33,297
-0.9%
|
44.44
|
USD 1,479,772
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
9,366
-0.2%
43.36
USD 406,110
|
9,366
-0.2%
|
43.36
|
USD 406,110
|
|
2022-01-05 |
2022-01-04 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
88,054
-2.3%
41.84
USD 3,684,355
|
88,054
-2.3%
|
41.84
|
USD 3,684,355
|
|
2022-01-05 |
2022-01-03 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
731
-1.5%
50.63
USD 37,013
|
731
-1.5%
|
50.63
|
USD 37,013
|
|
2022-01-05 |
2022-01-03 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
1,682
-3.4%
49.37
USD 83,049
|
1,682
-3.4%
|
49.37
|
USD 83,049
|
|
2022-01-05 |
2022-01-03 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
23,353
-32.3%
47.63
USD 1,112,245
|
23,353
-32.3%
|
47.63
|
USD 1,112,245
|
|
2022-01-05 |
2022-01-03 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
17,173
-0.4%
50.63
USD 869,534
|
17,173
-0.4%
|
50.63
|
USD 869,534
|
|
2022-01-05 |
2022-01-03 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
39,481
-1.0%
49.37
USD 1,949,355
|
39,481
-1.0%
|
49.37
|
USD 1,949,355
|
|
2022-01-05 |
2022-01-03 |
S
Sale
|
Boxer Capital, LLC
Non-Executive Director
Large shareholder
|
432,903
-10.0%
47.65
USD 20,626,183
|
432,903
-10.0%
|
47.65
|
USD 20,626,183
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
Lager Joanne Jenkins
Chief Medical Officer
Officer
|
7,000
-100.0%
51.90
USD 363,300
|
7,000
-100.0%
|
51.90
|
USD 363,300
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
Biniszkiewicz Detlev
Non-Executive Director
|
3,500
-100.0%
51.90
USD 181,650
|
3,500
-100.0%
|
51.90
|
USD 181,650
|
|
2021-12-22 |
2021-12-22 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
9,493
-13.0%
45.37
USD 430,697
|
9,493
-13.0%
|
45.37
|
USD 430,697
|
|
2021-12-22 |
2021-12-22 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
5,007
-6.4%
44.62
USD 223,412
|
5,007
-6.4%
|
44.62
|
USD 223,412
|
|
2021-12-22 |
2021-12-22 |
PS
Planned sale
|
Detheux Michel
Chief Executive Officer
Officer
|
149
-0.2%
44.92
USD 6,693
|
149
-0.2%
|
44.92
|
USD 6,693
|
|